Life Science Research

Neo Science Equipment’s & Chemicals Trading L.L.C. with Neo Science and Group partners with Future Care Alliance FZE, to introduce whole genome sequencing and interpretation to consumers and their physicians in the Middle East

Bruno Rosset, Founder and CEO of Future Care Alliance: "We are proud and delighted to partner with Neo Science who is relentlessly pushing the boundaries of science and technology, to empower people to live healthier, longer"

In June 2017Future Care Alliance entered into a collaboration agreement with Veritas Genetics, Harvard Medical School and Professor George Church. Professor Church set in motion countless genetic discoveries, including the Human Genome Project, the first initiative to map all the human genome. George along with a Group of visionaries and scientists, also initiated the Personal Genome Project at Harvard Medical School Read more...

 

gallery/just4me

The MerMade family of DNA / RNA synthesizers have been used to synthesize millions of high quality oligonucleotides across a broad range of applications. Our oligonucleotide synthesizers are flexible enough to fit a wide variety of DNA synthesis and RNA synthesis applications including gene synthesis, PCR, RNAi, dual labeled probes, microarrays, sequencing, and antisense experiments. Whether your DNA or RNA synthesizer requirements are a few custom oligos a week or several thousand a day we have a MerMade that will fit your needs Read more...

gallery/bioautomation

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support Read more...

Stratedigm was founded in 2004 with the mission to create flow cytometry products that break from convention. We believe that having to choose between compact yet low-end, or bulky yet high-end flow cytometers is an artifact of compromised design. Since 2008, Stratedigm has launched a comprehensive product line of flow cytometry platforms, all driven by the same intuitive software, enabling easy standardization across all of our products. Based on a foundation of patented, future-proof platforms with industry-leading performance, our product suite offers seamless upgradeability across our S1000 flow cytometers. With the industry’s most advanced high throughput plate loader and hotel, the S1000 family of flow cytometers go head-to-head with BD FACS Canto, BD LSR, and BD Fortessa flow cytometers at a fraction of the cost and size while offering a superior solution for conventional and high throughput flow cytometry applications. This is the power of cytometry without compromise. The vision and execution of six generations of the most advanced flow cytometers on the market today. “Cytometry without compromise” is not merely our mission statement, it is our passion; it is our decade long legacy Read more...

gallery/biolegend
gallery/stratelogo
gallery/智造logo
gallery/bgi

BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 2,137 publications, many in top-tier journals such as Nature and Science.

BGI is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI also has offices and laboratories located in Europe, North America and the Asia Pacific region. BGI currently operates in more than 100 countries and regions and works with more than 3000 medical institutions and more than 300 hospitals Read more...

MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, is committed to enabling effective and affordable healthcare solutions for all. Based on its proprietary technology, MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare.

MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive, life-long solutions, its mission is to develop and promote advanced life science tools for future healthcare Read more...

www.000webhost.com